MiRNAs in lung cancer: A link to aging

Ageing Research Reviews

Volumn 17, Issue , 2014, Pages 54-67

  Zagryazhskaya, Anna ^a   Zhivotovsky, Boris ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Aging; Cancer; Lung; MicroRNA; Sensitivity

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; BIOLOGICAL MARKER;

AGING; CANCER GROWTH; CANCER PROGNOSIS; CANCER RESISTANCE; EPIGENETICS; GENE EXPRESSION; HUMAN; LUNG CANCER; LUNG CANCER CELL LINE; RADIOSENSITIVITY; REVIEW; RNA TRANSCRIPTION; TREATMENT RESPONSE; ANIMAL; CARCINOMA; DRUG RESISTANCE; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; METASTASIS;

AGING; ANIMALS; BIOLOGICAL MARKERS; CARCINOMA; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS;

EID: 84906790677     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.02.009     Document Type: Review

References (142)

1. Akgun K.M., Crothers K., Pisani M. Epidemiology and management of common pulmonary diseases in older persons. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:276-291.
2. Anglicheau D., Muthukumar T., Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation 2010, 90:105-112.
3. Anisimov V.N., Zhukovskaya N.V., Loktionov A.S., Vasilyeva I.A., Kaminskaya E.V., Vakhtin Y.B. Influence of host age on lung colony forming capacity of injected rat rhabdomyosarcoma cells. Cancer Lett. 1988, 40:77-82.
4. Arora S., Ranade A.R., Tran N.L., Nasser S., Sridhar S., Korn R.L., Ross J.T., Dhruv H., Foss K.M., Sibenaller Z., Ryken T., Gotway M.B., Kim S., Weiss G.J. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int. J. Cancer 2011, 129:2621-2631.
5. Babar I.A., Czochor J., Steinmetz A., Weidhaas J.B., Glazer P.M., Slack F.J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol. Ther. 2011, 12:908-914.
6. Babizhayev M.A., Savel'yeva E.L., Moskvina S.N., Yegorov Y.E. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior. Am. J. Ther. 2011, 18:e209-e226.
7. Balca-Silva J., Sousa Neves S., Goncalves A.C., Abrantes A.M., Casalta-Lopes J., Botelho M.F., Sarmento-Ribeiro A.B., Silva H.C. Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines. Anticancer Res. 2012, 32:1603-1609.
8. Barshack I., Lithwick-Yanai G., Afek A., Rosenblatt K., Tabibian-Keissar H., Zepeniuk M., Cohen L., Dan H., Zion O., Strenov Y., Polak-Charcon S., Perelman M. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol. Res. Pract. 2010, 206:578-584.
9. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Orjalo A.V., Rodier F., Lithgow G.J., Campisi J. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Milano) 2009, 1:402-411.
10. Blagosklonny M.V. Prevention of cancer by inhibiting aging. Cancer Biol. Ther. 2008, 7:1520-1524.
11. Brueckner B., Stresemann C., Kuner R., Mund C., Musch T., Meister M., Sultmann H., Lyko F. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 2007, 67:1419-1423.
12. Brzezianska E., Dutkowska A., Antczak A. The significance of epigenetic alterations in lung carcinogenesis. Mol. Biol. Rep. 2013, 40:309-325.
13. Cai J., Fang L., Huang Y., Li R., Yuan J., Yang Y., Zhu X., Chen B., Wu J., Li M. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res. 2013, 73:5402-5415.
14. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2999-3004.
15. Catuogno S., Cerchia L., Romano G., Pognonec P., Condorelli G., de Franciscis V. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis. Oncogene 2013, 32:341-351.
16. Chang M.Y., Boulden J., Katz J.B., Wang L., Meyer T.J., Soler A.P., Muller A.J., Prendergast G.C. Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer. Cancer Res. 2007, 67:7605-7612.
17. Chen G., Umelo I.A., Lv S., Teugels E., Fostier K., Kronenberger P., Dewaele A., Sadones J., Geers C., De Greve J. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS ONE 2013, 8:e60317.
18. Chen S., Wang H., Ng W.L., Curran W.J., Wang Y. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81:1524-1529.
19. Cherni I., Weiss G.J. miRNAs in lung cancer: large roles for small players. Future Oncol. 2011, 7:1045-1055.
20. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13944-13949.
21. Crawford M., Brawner E., Batte K., Yu L., Hunter M.G., Otterson G.A., Nuovo G., Marsh C.B., Nana-Sinkam S.P. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 2008, 373:607-612.
22. Cui S.Y., Huang J.Y., Chen Y.T., Song H.Z., Feng B., Huang G.C., Wang R., Chen L.B., De W. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma. Mol. Cancer Res. 2013, 11:699-713.
23. Deng G., Sui G. Noncoding RNA in oncogenesis: a new era of identifying key players. Int. J. Mol. Sci. 2013, 14:18319-18349.
24. Derhovanessian E., Solana R., Larbi A., Pawelec G. Immunity, ageing and cancer. Immun. Ageing 2008, 5:11.
25. Doll R., Gray R., Hafner B., Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br. Med. J. 1980, 280:967-971.
26. Dong Z., Zhong Z., Yang L., Wang S., Gong Z. MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Lett. 2014, 343:249-257.
27. Donzelli S., Fontemaggi G., Fazi F., Di Agostino S., Padula F., Biagioni F., Muti P., Strano S., Blandino G. MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function. Cell Death Differ. 2012, 19:1038-1048.
28. Du L., Pertsemlidis A. microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Rev. 2010, 29:109-122.
29. Du L., Subauste M.C., DeSevo C., Zhao Z., Baker M., Borkowski R., Schageman J.J., Greer R., Yang C.R., Suraokar M., Wistuba I.I., Gazdar A.F., Minna J.D., Pertsemlidis A. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS ONE 2012, 7:e39167.
30. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., Volinia S., Guler G., Morrison C.D., Chan K.K., Marcucci G., Calin G.A., Huebner K., Croce C.M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15805-15810.
31. Feng B., Wang R., Chen L.B. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Cancer Lett. 2012, 317:184-191.
32. Feng B., Wang R., Song H.Z., Chen L.B. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 2012, 118:3365-3376.
33. Franchina T., Amodeo V., Bronte G., Savio G., Ricciardi G.R., Picciotto M., Russo A., Giordano A., Adamo V. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J. Cell. Physiol. 2014, 229:97-99.
34. Francia S., Michelini F., Saxena A., Tang D., de Hoon M., Anelli V., Mione M., Carninci P., d'Adda di Fagagna F. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 2012, 488:231-235.
35. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
36. Gadgeel S.M., Ramalingam S.S., Kalemkerian G.P. Treatment of lung cancer. Radiol. Clin. North Am. 2012, 50:961-974.
37. Galluzzi L., Morselli E., Vitale I., Kepp O., Senovilla L., Criollo A., Servant N., Paccard C., Hupe P., Robert T., Ripoche H., Lazar V., Harel-Bellan A., Dessen P., Barillot E., Kroemer G. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res. 2010, 70:1793-1803.
38. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., Ngankeu A., Taccioli C., Pichiorri F., Alder H., Secchiero P., Gasparini P., Gonelli A., Costinean S., Acunzo M., Condorelli G., Croce C.M. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009, 16:498-509.
39. Garzon R., Calin G.A., Croce C.M. MicroRNAs in Cancer. Annu. Rev. Med. 2009, 60:167-179.
40. Gibbons D.L., Lin W., Creighton C.J., Rizvi Z.H., Gregory P.A., Goodall G.J., Thilaganathan N., Du L., Zhang Y., Pertsemlidis A., Kurie J.M. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 2009, 23:2140-2151.
41. Grolleau-Julius A., Ray D., Yung R.L. The role of epigenetics in aging and autoimmunity. Clin. Rev. Allergy Immunol. 2010, 39:42-50.
42. Grosso S., Doyen J., Parks S.K., Bertero T., Paye A., Cardinaud B., Gounon P., Lacas-Gervais S., Noel A., Pouyssegur J., Barbry P., Mazure N.M., Mari B. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis. 2013, 4:e544.
43. Halpern M.T., Gillespie B.W., Warner K.E. Patterns of absolute risk of lung cancer mortality in former smokers. J. Natl. Cancer Inst. 1993, 85:457-464.
44. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
45. Harries L.W., Hernandez D., Henley W., Wood A.R., Holly A.C., Bradley-Smith R.M., Yaghootkar H., Dutta A., Murray A., Frayling T.M., Guralnik J.M., Bandinelli S., Singleton A., Ferrucci L., Melzer D. Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing. Aging Cell 2011, 10:868-878.
46. Havens M.A., Reich A.A., Duelli D.M., Hastings M.L. Biogenesis of mammalian microRNAs by a non-canonical processing pathway. Nucleic Acids Res. 2012, 40:4626-4640.
47. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010, 17:193-199.
48. Huang J.Y., Cui S.Y., Chen Y.T., Song H.Z., Huang G.C., Feng B., Sun M., De W., Wang R., Chen L.B. MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression. PLoS ONE 2013, 8:e72615.
49. Ibanez-Ventoso C., Yang M., Guo S., Robins H., Padgett R.W., Driscoll M. Modulated microRNA expression during adult lifespan in Caenorhabditis elegans. Aging Cell 2006, 5:235-246.
50. Incoronato M., Urso L., Portela A., Laukkanen M.O., Soini Y., Quintavalle C., Keller S., Esteller M., Condorelli G. Epigenetic regulation of miR-212 expression in lung cancer. PLoS ONE 2011, 6:e27722.
51. Jansson M.D., Lund A.H. MicroRNA and cancer. Mol. Oncol. 2012, 6:590-610.
52. Jeon H.S., Lee S.Y., Lee E.J., Yun S.C., Cha E.J., Choi E., Na M.J., Park J.Y., Kang J., Son J.W. Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. Lung Cancer 2012, 76:171-176.
53. Jeong S.H., Wu H.G., Park W.Y. LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp.Mol. Med. 2009, 41:912-918.
54. Kaduthanam S., Gade S., Meister M., Brase J.C., Johannes M., Dienemann H., Warth A., Schnabel P.A., Herth F.J., Sultmann H., Muley T., Kuner R. Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 2013, 80:223-227.
55. Kang J., Kim E., Kim W., Seong K.M., Youn H., Kim J.W., Kim J., Youn B. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines. J. Biol. Chem. 2013, 288:27343-27357.
56. Kang S.M., Lee H.J., Cho J.Y. MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. Cancer Lett. 2013, 335:487-494.
57. Ke Y., Zhao W., Xiong J., Cao R. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. FEBS Lett. 2013, 587:3153-3157.
58. Kesanakurti D., Maddirela D.R., Chittivelu S., Rao J.S., Chetty C. Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer. Biochem. Biophys. Res. Commun. 2013, 434:627-633.
59. Kim D.H., Saetrom P., Snove O., Rossi J.J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16230-16235.
60. Kraemer A., Anastasov N., Angermeier M., Winkler K., Atkinson M.J., Moertl S. MicroRNA-mediated processes are essential for the cellular radiation response. Radiat. Res. 2011, 176:575-586.
61. Ksiazek-Winiarek D.J., Kacperska M.J., Glabinski A. MicroRNAs as novel regulators of neuroinflammation. Mediators Inflamm. 2013, 2013:172351.
62. Kulesa P.M., Kasemeier-Kulesa J.C., Teddy J.M., Margaryan N.V., Seftor E.A., Seftor R.E., Hendrix M.J. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3752-3757.
63. Kumar M.S., Pester R.E., Chen C.Y., Lane K., Chin C., Lu J., Kirsch D.G., Golub T.R., Jacks T. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 2009, 23:2700-2704.
64. Larsen J.E., Cascone T., Gerber D.E., Heymach J.V., Minna J.D. Targeted therapies for lung cancer: clinical experience and novel agents. Cancer J. 2011, 17:512-527.
65. Lee K.M., Choi E.J., Kim I.A. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother. Oncol. 2011, 101:171-176.
66. Lee P.N., Forey B.A., Coombs K.J. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 2012, 12:385.
67. Lei L., Huang Y., Gong W. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. Oncol. Rep. 2013, 30:2897-2902.
68. Leucci E., Zriwil A., Gregersen L.H., Jensen K.T., Obad S., Bellan C., Leoncini L., Kauppinen S., Lund A.H. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene 2012, 31:5081-5089.
69. Li D., Wang Q., Liu C., Duan H., Zeng X., Zhang B., Li X., Zhao J., Tang S., Li Z., Xing X., Yang P., Chen L., Zeng J., Zhu X., Zhang S., Zhang Z., Ma L., He Z., Wang E., Xiao Y., Zheng Y., Chen W. Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation. Toxicol. Sci. 2012, 125:382-391.
70. Li Y., Li L., Guan Y., Liu X., Meng Q., Guo Q. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN. Biochem. Biophys. Res. Commun. 2013, 440:604-610.
71. Li Z.H., Zhang H., Yang Z.G., Wen G.Q., Cui Y.B., Shao G.G. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer. J. Int. Med. Res. 2013, 41:1437-1444.
72. Ling H., Fabbri M., Calin G.A. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 2013, 12:847-865.
73. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr. Opin. Cell Biol. 2008, 20:214-221.
74. Liu S.V., Fabbri M., Gitlitz B.J., Laird-Offringa I.A. Epigenetic therapy in lung cancer. Front. Oncol. 2013, 3:135.
75. Liu Y.J., Lin Y.F., Chen Y.F., Luo E.C., Sher Y.P., Tsai M.H., Chuang E.Y., Lai L.C. MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells. PLoS ONE 2013, 8:e62383.
76. Liu Z.L., Wang H., Liu J., Wang Z.X. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol. Cell. Biochem. 2013, 372:35-45.
77. Lodygin D., Tarasov V., Epanchintsev A., Berking C., Knyazeva T., Korner H., Knyazev P., Diebold J., Hermeking H. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
78. Lopez-Otin C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217.
79. Lopez-Serra P., Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012, 31:1609-1622.
80. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
81. Lu L., Katsaros D., de la Longrais I.A., Sochirca O., Yu H. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 2007, 67:10117-10122.
82. Lujambio A., Ropero S., Ballestar E., Fraga M.F., Cerrato C., Setien F., Casado S., Suarez-Gauthier A., Sanchez-Cespedes M., Git A., Spiteri I., Das P.P., Caldas C., Miska E., Esteller M. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007, 67:1424-1429.
83. Luo W., Huang B., Li Z., Li H., Sun L., Zhang Q., Qiu X., Wang E. MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met. PLoS ONE 2013, 8:e64759.
84. Maes O.C., An J., Sarojini H., Wang E. Murine microRNAs implicated in liver functions and aging process. Mech. Ageing Dev. 2008, 129:534-541.
85. Maes O.C., Sarojini H., Wang E. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J. Cell. Physiol. 2009, 221:109-119.
86. McCullough K.D., Coleman W.B., Smith G.J., Grisham J.W. Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res. 1997, 57:1807-1813.
87. Melo S.A., Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011, 585:2087-2099.
88. Metheetrairut C., Slack F.J. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr. Opin. Genet. Dev. 2013, 23:12-19.
89. Miao L.J., Huang S.F., Sun Z.T., Gao Z.Y., Zhang R.X., Liu Y., Wang J. MiR-449c targets c-Myc and inhibits NSCLC cell progression. FEBS Lett. 2013, 587:1359-1365.
90. Nana-Sinkam S.P., Croce C.M. Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 2013, 93:98-104.
91. Nasser M.W., Datta J., Nuovo G., Kutay H., Motiwala T., Majumder S., Wang B., Suster S., Jacob S.T., Ghoshal K. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 2008, 283:33394-33405.
92. O'Rourke M.A., Feussner J.R., Feigl P., Laszlo J. Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly. J. Am. Med. Assoc. 1987, 258:921-926.
93. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 2008, 30:460-471.
94. Osada H., Takahashi T. let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci. 2011, 102:9-17.
95. Ozsolak F., Poling L.L., Wang Z., Liu H., Liu X.S., Roeder R.G., Zhang X., Song J.S., Fisher D.E. Chromatin structure analyses identify miRNA promoters. Genes Dev. 2008, 22:3172-3183.
96. Peng Y., Dai Y., Hitchcock C., Yang X., Kassis E.S., Liu L., Luo Z., Sun H.L., Cui R., Wei H., Kim T., Lee T.J., Jeon Y.J., Nuovo G.J., Volinia S., He Q., Yu J., Nana-Sinkam P., Croce C.M. Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:15043-15048.
97. Penna E., Orso F., Cimino D., Vercellino I., Grassi E., Quaglino E., Turco E., Taverna D. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. Cancer Res. 2013, 73:4098-4111.
98. Peto R., Darby S., Deo H., Silcocks P., Whitley E., Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000, 321:323-329.
99. Pramanik D., Campbell N.R., Karikari C., Chivukula R., Kent O.A., Mendell J.T., Maitra A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 2011, 10:1470-1480.
100. Pu X., Roth J.A., Hildebrandt M.A., Ye Y., Wei H., Minna J.D., Lippman S.M., Wu X. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer Res. 2013, 73:1867-1875.
101. Qiu T., Zhou L., Wang T., Xu J., Wang J., Chen W., Zhou X., Huang Z., Zhu W., Shu Y., Liu P. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Int. J. Mol. Med. 2013, 32:593-598.
102. Ranade A.R., Cherba D., Sridhar S., Richardson P., Webb C., Paripati A., Bowles B., Weiss G.J. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J. Thorac. Oncol. 2010, 5:1273-1278.
103. Rodier F., Campisi J. Four faces of cellular senescence. J. Cell Biol. 2011, 192:547-556.
104. Romano G., Acunzo M., Garofalo M., Di Leva G., Cascione L., Zanca C., Bolon B., Condorelli G., Croce C.M. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:16570-16575.
105. Sachdeva M., Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010, 70:378-387.
106. Saini H.K., Griffiths-Jones S., Enright A.J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17719-17724.
107. Salim H., Akbar N.S., Zong D., Vaculova A.H., Lewensohn R., Moshfegh A., Viktorsson K., Zhivotovsky B. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br. J. Cancer 2012, 107:1361-1373.
108. Salim H., Arvanitis A., de Petris L., Kanter L., Haag P., Zovko A., Ozata D.M., Lui W.O., Lundholm L., Zhivotovsky B., Lewensohn R., Viktorsson K. miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression. Genes Chromosomes Cancer 2013, 52:895-911.
109. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
110. Sher T., Dy G.K., Adjei A.A. Small cell lung cancer. Mayo Clinic proceedings. Mayo Clin. 2008, 83:355-367.
111. Shin S., Cha H.J., Lee E.M., Lee S.J., Seo S.K., Jin H.O., Park I.C., Jin Y.W., An S. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int. J. Oncol. 2009, 35:81-86.
112. Soon P., Kiaris H. MicroRNAs in the tumour microenvironment: big role for small players. Endocr. Relat. Cancer 2013, 20:R257-R267.
113. Suda K., Tomizawa K., Mizuuchi H., Ito S., Kitahara H., Shimamatsu S., Kohno M., Yoshida T., Okamoto T., Maehara Y., Yatabe Y., Mitsudomi T. Genetic and prognostic differences of non-small cell lung cancer between elderly patients and younger counterparts. Aging Dis. 2012, 3:438-443.
114. Surova O., Akbar N.S., Zhivotovsky B. Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation. PLoS ONE 2012, 7:e33134.
115. Taft R.J., Simons C., Nahkuri S., Oey H., Korbie D.J., Mercer T.R., Holst J., Ritchie W., Wong J.J., Rasko J.E., Rokhsar D.S., Degnan B.M., Mattick J.S. Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nat. Struct. Mol. Biol. 2010, 17:1030-1034.
116. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12481-12486.
117. Uchino K., Ochiya T., Takeshita F. RNAi therapeutics and applications of microRNAs in cancer treatment. Jpn. J. Clin. Oncol. 2013, 43:596-607.
118. Ueno T., Toyooka S., Suda K., Soh J., Yatabe Y., Miyoshi S., Matsuo K., Mitsudomi T. Impact of age on epidermal growth factor receptor mutation in lung cancer. Lung Cancer 2012, 78:207-211.
119. Ulivi P., Foschi G., Mengozzi M., Scarpi E., Silvestrini R., Amadori D., Zoli W. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Int. J. Mol. Sci. 2013, 14:10332-10342.
120. Wang Q., Zhong M., Liu W., Li J., Huang J., Zheng L. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP). Exp. Lung Res. 2011, 37:427-434.
121. Wang X., Dong K., Gao P., Long M., Lin F., Weng Y., Ouyang Y., Ren J., Zhang H. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status. Cancer Biother. Radiopharm. 2013, 28:45-50.
122. Wang X.C., Du L.Q., Tian L.L., Wu H.L., Jiang X.Y., Zhang H., Li D.G., Wang Y.Y., Wu H.Y., She Y., Liu Q.F., Fan F.Y., Meng A.M. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 2011, 72:92-99.
123. Wang X.C., Wang W., Zhang Z.B., Zhao J., Tan X.G., Luo J.C. Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat. Oncol. 2013, 8:146.
124. Wang Y., Zhang X., Liu L., Li H., Yu J., Wang C., Ren X. Clinical implication of microRNA for lung cancer. Cancer Biother. Radiopharm. 2013, March 15, PMID: 23496233 [Epub ahead of print].
125. Wang Y.S., Wang Y.H., Xia H.P., Zhou S.W., Schmid-Bindert G., Zhou C.C. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. Asian Pac. J. Cancer Prev. 2012, 13:255-260.
126. Wang Z., Yao H., Lin S., Zhu X., Shen Z., Lu G., Poon W.S., Xie D., Lin M.C., Kung H.F. Transcriptional and epigenetic regulation of human microRNAs. Cancer Lett. 2013, 331:1-10.
127. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
128. Wei J., Gao W., Zhu C.J., Liu Y.Q., Mei Z., Cheng T., Shu Y.Q. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin. J. Cancer 2011, 30:407-414.
129. William W.N., Glisson B.S. Novel strategies for the treatment of small-cell lung carcinoma. Nat. Rev. Clin. Oncol. 2011, 8:611-619.
130. Williams A.E., Perry M.M., Moschos S.A., Lindsay M.A. microRNA expression in the aging mouse lung. BMC Genomics 2007, 8:172.
131. Virts E.L., Thoman M.L. Age-associated changes in miRNA expression profiles in thymopoiesis. Mech. Ageing Dev. 2010, 131:743-748.
132. Wu X., Liu T., Fang O., Leach L.J., Hu X., Luo Z. miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27 kip1. Oncogene 2013, April 15, PMID: 23584484 [Epub ahead of print]. 10.1038/onc.2013.108.
133. Xi S., Xu H., Shan J., Tao Y., Hong J.A., Inchauste S., Zhang M., Kunst T.F., Mercedes L., Schrump D.S. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. J. Clin. Invest. 2013, 123:1241-1261.
134. Yang J., Liu H., Wang H., Sun Y. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Pathol. Res. Pract. 2013, 209:490-494.
135. Yeo J.H., Chong M.M. Many routes to a micro RNA. IUBMB Life 2011, 63:972-978.
136. Zandberga E., Kozirovskis V., Abols A., Andrejeva D., Purkalne G., Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer 2013, 52:356-369.
137. Zhang W.C., Liu J., Xu X., Wang G. The role of microRNAs in lung cancer progression. Med. Oncol. 2013, 30:675.
138. Zhang X., Zhu J., Xing R., Tie Y., Fu H., Zheng X., Yu B. miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1. Lung Cancer 2012, 77:488-494.
139. Zhao B., Han H., Chen J., Zhang Z., Li S., Fang F., Zheng Q., Ma Y., Zhang J., Wu N., Yang Y. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett. 2014, 342:43-51.
140. Zhu W., Shan X., Wang T., Shu Y., Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J Cancer 2010, 127:2520-2529.
141. Zhu X., Li H., Long L., Hui L., Chen H., Wang X., Shen H., Xu W. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim. Biophys. Sin. 2012, 44:519-526.
142. Zhu X., Li Y., Shen H., Li H., Long L., Hui L., Xu W. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett. 2013, 587:73-81.